Drug intelligence / Profile preview

antithrombin knockdown antibody

Development stage
Preclinical
Modality
Antibody-Based Therapeutics
01

Overview

An antithrombin knockdown antibody (or anti-antithrombin antibody) is an antibody designed to bind and neutralize or deplete antithrombin (antithrombin III), a key natural anticoagulant that inhibits thrombin and factor Xa. In research settings, such as in vitro thrombin generation assays, polyclonal antibodies (e.g., sheep anti-human antithrombin antibodies) are used to experimentally deplete antithrombin levels to simulate hemostatic rebalancing. Therapeutically, anti-antithrombin antibodies and single-domain antibodies (nanobodies) are being explored as non-factor replacement therapies for hemophilia A, hemophilia B, and other rare coagulation factor deficiencies. By blocking the inhibitory activity of antithrombin, these antibodies promote thrombin generation and restore hemostasis in patients with bleeding diatheses.

Other names
anti-antithrombin antibodyanti-antithrombin III antibodyantithrombin-neutralizing antibodysheep anti-human antithrombin antibody
02

Targets

F2 (Thrombin)ATIII (Antithrombin III)

Beyond the preview

Go deeper on antithrombin knockdown antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on antithrombin knockdown antibody.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call